Dr. Andrée Bates is a leading Artificial Intelligence thought leader and the founder and CEO of Eularis, a firm focused on tackling pharma industry challenges with artificial intelligence since 2003. She has worked in this space for pharma in Europe, USA, Canada, LATAM, EMEA, Japan, UK and China for over 20 years and in pharmaceuticals for 30 years. Dr. Bates has led Artificial Intelligence programmes for numerous top-tier pharmaceutical companies in diverse areas such as R&D, clinical trials, medical affairs and sales and marketing.
These have all resulted in measurable efficiency and growth in profit and market share for her clients. Part of her success with AI is due to the initial strategic planning of AI across healthcare companies’ value chain from a business perspective to ensure that pharma leaders can leverage the value of AI effectively to solve their unique growth and efficiency challenges successfully.
She is also a guest lecturer in 6 University MBA programmes in Health Innovation and AI and is also an Assessor for Innovate UK, UK’s national innovation agency, with her area of specialty being AI-focused start-up grants. She also hosts a podcast ‘AI for Pharma Growth’ that explores AI that is relevant to pharma.
Veritux independent consultants are available where you need them – in all major markets and every global region.
